Gapping down
Other news:
- ATXI -54.7% (announced it has received a Complete Response Letter from the FDA regarding the Company's New Drug Application for IV tramadol)
- PCG -7% (files an electric incident report with the California Public Utilities Commission)
- FOLD -6.2% (reports interim clinical data for CLN6 Batten disease gene therapy)
- IMGN -2.5% (raises $54.8 million in gross proceeds through its at-the-market facility)
- VXX -1.9% (trading lower in tandem with strength in US futures)
Analyst comments:
- GME -3.3% (downgraded to Hold from Buy at Jefferies)
- XLNX -1.7% (downgraded to Neutral from Outperform at Robert W. Baird)
- TRV -1.5% (downgraded to Underweight from Neutral at JP Morgan)
- PING -0.8% (downgraded to Neutral from Buy at Mizuho)
- ANET -0.7% (downgraded to Neutral from Buy at Citigroup)
- UAL -0.5% (downgraded to Equal Weight from Overweight at Barclays)